Guifang Xu
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment 12
- Molecular Biology top 5%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 8
-
- Gastric Cancer Management and Outcomes 26
- Metastasis and carcinoma case studies 10
-
- Gastrointestinal disorders and treatments 9
- Cholangiocarcinoma and Gallbladder Cancer Studies 9
- Helicobacter pylori-related gastroenterology studies 8
- Co-authors
- Guoliang XuTianpeng GuFan GuoLinyu ShiJinsong LiWei LiuHaiping WuZixin Deng
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Guifang Xu
86 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 476
- Gastroenterology 170
- Molecular Biology 1.6k
- Oncology 457
- Pulmonary and Respiratory Medicine 539
Countries citing papers authored by Guifang Xu
This map shows the geographic impact of Guifang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guifang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guifang Xu more than expected).
Fields of papers citing papers by Guifang Xu
This network shows the impact of papers produced by Guifang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guifang Xu. The network helps show where Guifang Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guifang Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 23 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 15 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 8 | |
| 14 | 2019 | 1 | |
| 15 | 2019 | 22 | |
| 16 | 2018 | 17 | |
| 17 | 2015 | 1 | |
| 18 | 2014 | 3 | |
| 19 | 2012 | 25 | |
| 20 | Antidiabetes and Angiotensin Converting Enzyme Inhibitory Activity of Sonchus asper (L) Hill Extract | 2011 | 13 |
About Guifang Xu
Guifang Xu is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 89 papers that have together received 2.7k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (26 papers), Gastrointestinal Tumor Research and Treatment (12 papers), Metastasis and carcinoma case studies (10 papers), Gastrointestinal disorders and treatments (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (476 citations), Gastroenterology (170 citations) and Molecular Biology (1.6k citations). Guifang Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Guoliang Xu, Tianpeng Gu, Fan Guo, Linyu Shi, Jinsong Li, Wei Liu, Haiping Wu, Zixin Deng, Khursheed Iqbal and Xinyi He. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.